Valuation: Cabio Biotech (Wuhan) Co., Ltd.

Capitalization 4.2B 586M 501M 466M 434M 802M 50.24B 891M 5.59B 2.14B 23.52B 2.2B 2.15B 86.29B P/E ratio 2025 *
27x
P/E ratio 2026 * 22.4x
Enterprise value 4.2B 586M 501M 466M 434M 802M 50.24B 891M 5.59B 2.14B 23.52B 2.2B 2.15B 86.29B EV / Sales 2025 *
6.25x
EV / Sales 2026 * 5.2x
Free-Float
49.79%
Yield 2025 *
0.96%
Yield 2026 * 1.04%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.04%
1 week-0.76%
Current month-0.83%
1 month-1.03%
3 months+4.79%
6 months+44.00%
Current year+31.06%
More quotes
1 week 24.65
Extreme 24.65
25.3
1 month 23.72
Extreme 23.72
25.75
Current year 16.93
Extreme 16.93
29.21
1 year 13.94
Extreme 13.94
30.12
3 years 9.98
Extreme 9.98
38.98
5 years 9.98
Extreme 9.98
49.5
10 years 9.98
Extreme 9.98
49.5
More quotes
Manager TitleAgeSince
Chief Executive Officer 60 2004-09-21
Director of Finance/CFO 60 2015-12-14
Chief Tech/Sci/R&D Officer 56 2004-09-21
Director TitleAgeSince
Chairman 60 2004-09-21
Director/Board Member 60 2015-12-14
Director/Board Member 60 2015-12-14
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.04%-0.76%+88.65%+4.41% 586M
+1.26%-3.07%+104.10%+581.39% 9.87B
-0.18%+0.09%+6.91%+4.15% 9.35B
-0.60%+0.63%+5.25%+145.61% 7.36B
+1.80%+2.59%-10.28%-8.41% 3.31B
+0.87%+2.29%-13.05%-41.41% 2.72B
-0.25%-5.22%+45.88%-14.54% 1.69B
-1.14%-1.73%+10.89%-0.20% 1.06B
0.00%0.00%+135.62%+16.22% 1.05B
-1.83%+2.00%-5.65%-55.15% 1.04B
Average -0.00%+0.38%+36.83%+63.21% 3.8B
Weighted average by Cap. +0.29%+0.21%+35.21%+174.78%
See all sector performances

Financials

2025 *2026 *
Net sales 671M 93.67M 80.1M 74.61M 69.39M 128M 8.04B 142M 894M 342M 3.76B 351M 344M 13.8B 807M 113M 96.26M 89.66M 83.39M 154M 9.66B 171M 1.07B 411M 4.52B 422M 413M 16.59B
Net income 155M 21.64M 18.51M 17.24M 16.03M 29.62M 1.86B 32.92M 207M 78.97M 869M 81.17M 79.5M 3.19B 187M 26.05M 22.27M 20.75M 19.3M 35.66M 2.24B 39.63M 249M 95.05M 1.05B 97.7M 95.68M 3.84B
Net Debt - -
More financial data * Estimated data
Logo Cabio Biotech (Wuhan) Co., Ltd.
Cabio Biotech Wuhan Co Ltd is a China-based company principally engaged in biotechnology business. The Company is mainly engaged in the research and development, production and sales of polyunsaturated fatty acids arachidonic acid (ARA), algal oil docosahexaenoic acid (DHA) and sialic acid (SA), and natural beta-carotene products. Its products are mainly used in infant formula food, dietary supplements, nutritional health food and formula food for special medical purposes. The Company integrates industrial strain-oriented optimization technology, fermentation fine control technology, and efficient separation, purification and preparation technology, and provides nutrient products and innovative solutions for customers in the global nutrition and health field through sustainable microbial synthesis and manufacturing methods. The Company mainly conducts its business in domestic and overseas markets.
Employees
565
More about the company
Date Price Change Volume
25-07-11 24.94 ¥ +0.04% 1,575,532
25-07-10 24.93 ¥ +0.04% 1,304,354
25-07-09 24.92 ¥ -0.68% 1,468,871
25-07-08 25.09 ¥ +0.24% 1,609,529
25-07-07 25.03 ¥ -0.40% 1,234,659

End-of-day quote Shanghai S.E., July 10, 2025

More quotes
Trading Rating
Investor Rating
ESG MSCI
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
24.94CNY
Average target price
28.00CNY
Spread / Average Target
+12.27%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688089 Stock